BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 19571069)

  • 1. Multiple hereditary exostosis, EXT genes, and skeletal development.
    Sandell LJ
    J Bone Joint Surg Am; 2009 Jul; 91 Suppl 4():58-62. PubMed ID: 19571069
    [No Abstract]   [Full Text] [Related]  

  • 2. The link between heparan sulfate and hereditary bone disease: finding a function for the EXT family of putative tumor suppressor proteins.
    Duncan G; McCormick C; Tufaro F
    J Clin Invest; 2001 Aug; 108(4):511-6. PubMed ID: 11518722
    [No Abstract]   [Full Text] [Related]  

  • 3. Reevaluation of a genetic model for the development of exostosis in hereditary multiple exostosis.
    Hall CR; Cole WG; Haynes R; Hecht JT
    Am J Med Genet; 2002 Sep; 112(1):1-5. PubMed ID: 12239711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycosaminoglycans in the blood of hereditary multiple exostoses patients: Half reduction of heparan sulfate to chondroitin sulfate ratio and the possible diagnostic application.
    Anower-E-Khuda MF; Matsumoto K; Habuchi H; Morita H; Yokochi T; Shimizu K; Kimata K
    Glycobiology; 2013 Jul; 23(7):865-76. PubMed ID: 23514715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diminished levels of the putative tumor suppressor proteins EXT1 and EXT2 in exostosis chondrocytes.
    Bernard MA; Hall CE; Hogue DA; Cole WG; Scott A; Snuggs MB; Clines GA; Lüdecke HJ; Lovett M; Van Winkle WB; Hecht JT
    Cell Motil Cytoskeleton; 2001 Feb; 48(2):149-62. PubMed ID: 11169766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EXT 1 gene mutation induces chondrocyte cytoskeletal abnormalities and defective collagen expression in the exostoses.
    Legeai-Mallet L; Rossi A; Benoist-Lasselin C; Piazza R; Mallet JF; Delezoide AL; Munnich A; Bonaventure J; Zylberberg L
    J Bone Miner Res; 2000 Aug; 15(8):1489-500. PubMed ID: 10934647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular and cellular basis of exostosis formation in hereditary multiple exostoses.
    Reijnders CM; Hogendoorn PC; Bovée JV
    Int J Exp Pathol; 2009 Apr; 90(2):190-1; author reply 191-3. PubMed ID: 19335558
    [No Abstract]   [Full Text] [Related]  

  • 8. [Proteoglycan core glycosyltransferases].
    Uyama T; Kitagawa H; Sugahara K
    Tanpakushitsu Kakusan Koso; 2003 Jun; 48(8 Suppl):1019-26. PubMed ID: 12807004
    [No Abstract]   [Full Text] [Related]  

  • 9. New perspectives on the molecular basis of hereditary bone tumours.
    McCormick C; Duncan G; Tufaro F
    Mol Med Today; 1999 Nov; 5(11):481-6. PubMed ID: 10529789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular and cellular basis of exostosis formation in hereditary multiple exostoses.
    Trebicz-Geffen M; Robinson D; Evron Z; Glaser T; Fridkin M; Kollander Y; Vlodavsky I; Ilan N; Law KF; Cheah KS; Chan D; Werner H; Nevo Z
    Int J Exp Pathol; 2008 Oct; 89(5):321-31. PubMed ID: 18452536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [From gene to disease; hereditary multiple exostoses].
    Wuyts W; Bovée JV; Hogendoorn PC
    Ned Tijdschr Geneeskd; 2002 Jan; 146(4):162-4. PubMed ID: 11845565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [EXT1 and EXT2 mutation identified by denaturing high performance liquid chromatograph in three families with hereditary multiple exostoses].
    Zhang M; Liu SG; Li FF; Zhou WH; Jin XH; Ma X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec; 24(6):646-51. PubMed ID: 18067075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis of multiple exostoses: mutations in the EXT1 and EXT2 genes.
    Wuyts W; Van Hul W
    Hum Mutat; 2000; 15(3):220-7. PubMed ID: 10679937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparan sulfate in skeletal development, growth, and pathology: the case of hereditary multiple exostoses.
    Huegel J; Sgariglia F; Enomoto-Iwamoto M; Koyama E; Dormans JP; Pacifici M
    Dev Dyn; 2013 Sep; 242(9):1021-32. PubMed ID: 23821404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel deletion mutation of the EXT2 gene in a large Chinese pedigree with hereditary multiple exostosis.
    Xiao CY; Wang J; Zhang SZ; Van Hul W; Wuyts W; Qiu WM; Wu H; Zhang G
    Br J Cancer; 2001 Jul; 85(2):176-81. PubMed ID: 11461073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary multiple exostosis.
    Ryckx A; Somers JF; Allaert L
    Acta Orthop Belg; 2013 Dec; 79(6):597-607. PubMed ID: 24563962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary multiple exostoses: anatomical distribution and burden of exostoses is dependent upon genotype and gender.
    Clement ND; Porter DE
    Scott Med J; 2014 Feb; 59(1):35-44. PubMed ID: 24413927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The exostosin family: proteins with many functions.
    Busse-Wicher M; Wicher KB; Kusche-Gullberg M
    Matrix Biol; 2014 Apr; 35():25-33. PubMed ID: 24128412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hereditary multiple exostoses: report of 5 cases within 3 generations in a family].
    Zhang XF; Xu YG; Chen WX
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Jun; 9(3):258-9. PubMed ID: 17582272
    [No Abstract]   [Full Text] [Related]  

  • 20. A 651-665delinsTT mutation in EXT1 causes hereditary multiple exostoses.
    Shi YR; Wu JY; Tsai FJ; Lee CC; Tsai CH
    Hum Mutat; 2001 Feb; 17(2):158. PubMed ID: 11180615
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.